Multiple: Gastroesophageal Reflux Disease
An update on the use of pantoprazole as a treatment for gastroesophageal reflux disease
... Abstract: Gastroesophageal reflux disease (GERD) is a chronic, recurrent disease that affects nearly 19 million people in the ...in multiple forms: a delayed-release oral capsule, oral ...
6
Prospective study on effect of Helicobacter pylori on gastroesophageal reflux disease
... injury. 1 The main causes of GERD are secondary to permanent laxity of the collar sling musculature in the lower end of esophagus known as lower esophageal sphincter (LES), with a resultant distension of the gastric ...
5
Role of tight junction proteins in gastroesophageal reflux disease
... Data are expressed as absolute number, relative propor- tion, median + range or mean ± standard deviation (SD) if not stated otherwise. Since the majority of data sets revealed skewed distribution, non-parametric ...
12
Validation of a survey methodology for gastroesophageal reflux disease in China
... Construct validity evaluates whether an instrument actu- ally measures the phenomena that it theoretically pre- dicts; correlation and factor analysis were used to evaluate construct validity in this study. Factor ...
12
Dietary guideline adherence for gastroesophageal reflux disease
... [33-36]. Multiple differences exist between beverage types including alcohol content (lower in beer), volume (higher per serving for beer), and carbonation (present in beer but not ...
9
Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients – focus on esomeprazole
... of multiple random- ized controlled studies have shown that PPI, misoprostol, and double-dose histamine-2-recpetor antagonist (H2RA) are effective at preventing chronic NSAID related endoscopic gastric and ...
11
Sleeve Gastrectomy and Gastroesophageal Reflux Disease
... Multiple anatomical or physiologic factors have been proposed and identified that could contribute to the worsening of reflux or the de novo development of GERD after SG. Several studies [10] [11] have ...
6
Management of gastroesophageal reflux disease and erosive esophagitis in pediatric patients: Focus on delayed-release esomeprazole
... The powerful action of PPIs, in addition to elevating gas- tric pH, also leads to reducing 24-hour intragastric volume, facilitating gastric emptying, and reducing refluxate volume. The only PPIs used in children are ...
7
Underrecognized comorbidities of chronic obstructive pulmonary disease
... heart disease, heart failure, atrial fibrillation, hypertension); osteoporosis (frequently associated with weight loss and sarcopenia); anxiety and depression; lung cancer; infections; metabolic syndrome and ...
11
Multinucleated stromal giant cells in the gastroesophageal junctional and gastric mucosa: a retrospective study
... Reactive/reparative changes of the gastrointestinal tract are commonly observed in the daily practice of surgical pathology, secondary to infection, inflammation, foreign body, and others. Multinucleated cells are often ...
5
Determinants of Gastroesophageal Reflux Disease (GERD) severity and Utilization of Proton Pump Inhibitors among GERD Patients: A Cross-Sectional Study
... Protracted usage of PPIs can lead to its long term adverse effects such as chronic kidney disease (CKD), Clostridium difficile infection (CDI), community-acquired pneumonia (CAP), osteoporosis etc (Gikas et al., ...
5
Partial response to proton pump inhibitor therapy for GERD: observational study of patient characteristics, burden of disease, and costs in the USA
... Eligible patients were adults ($18 years) identified as being partial responders to optimized PPI treatment (at, or prior to, the enrollment visit) for GERD ($6 months’ documented history of GERD symptoms) who had ...
11
Parental perceptions of dental health and need for treatment in children with epilepsy: a multicenter cross-sectional study
... or gastroesophageal reflux disease, motor disability, or cognitive disability; frequency of brushing teeth; recently been to a dentist; type of antiepileptic dug used; cause of epileptic seizure; and ...
8
Metoclopramide for the Treatment of Gastroesophageal Reflux Disease in Infants: A Systematic Review
... reflux episodes when the patients were treated with metoclopramide, from a mean of 41 (SD: 29.7) during the placebo period versus a mean of 54 (SD: 44.9) epi- sodes per 24 hours during the metoclopramide period. ...
9
Risk factors for Barrett’s esophagus among patients with gastroesophageal reflux disease: A community clinic-based case-control study
... Central adiposity was a risk factor for SIM and BE among our study population with chronic GERD symptoms. The strength of the associations between either WHR or WTR and the BE case groups were not as strong as we found ...
31
Pharmacokinetics, absorption, and excretion of radiolabeled revexepride: a Phase I clinical trial using a microtracer and accelerator mass spectrometry-based approach
... Keywords: accelerator mass spectrometry, gastroesophageal reflux disease, pharmacokinetics, revexepride, 5-hydroxytryptamine receptor 4 agonist2. Introduction.[r] ...
8
Lifestyle factors affecting gastroesophageal reflux disease symptoms: a cross-sectional study of healthy 19864 adults using FSSG scores
... Though there have been very few studies showing the association of GERD with hypertension or antihyperten- sive drug use, a cross-sectional study from Japan reported positive correlation between hypertension and ...
11
New Pharmacological Therapies for Treatment of Gastroesophageal Reflux Disease
... for lansoprazole (not statistically significant). But the therapeutic gain (difference in healing rate) was small, that is, 5-7%. Similarly, post-hoc analysis revealed better healing of moderate-to- severe esophagitis ...
11
Laparoscopic Nissen Fundoplication in Korean Patients with Gastroesophageal Reflux Disease
... Evidence of laparoscopic antireflux surgery is scarce in Korea, and the first report of laparoscopic fundoplication in adult was published in 1996. 7 Reasons for the scarcity of laparoscopic fundopli- cation is that ...
6
Clinical utility and tolerability of JSPH-1 wireless esophageal pH monitoring system
... acid reflux were not ...taking, reflux symptoms(chest discomfort, acid reflux, heart burn)and other events which would be useful in the later interpretation of pH ...
7